UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore the top cash back cards that provide the highest rewards. Learn how to maximize your earnings with these fantastic options.
26,275 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
D-Wave Quantum stock is rallying on recent funding news and government support. This guide breaks down what that mean...
D-Wave Quantum spiked on news of fresh government funding but ended lower as bulls and bears debated quantum advantag...
AAPD’s 3.43% yield looks appealing, but the bear-on-Apple fund relies on collateral interest instead of dividends. A ...
Guidewire's 2026 earnings narrative centers on cloud shift, product mix, and disciplined growth. This guide breaks do...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
Nvidia stands at the center of the AI boom. This piece lays out why could nvidia reach trillion is a real, trackable ...
Nu Holdings is poised for a volatile after-hours session as it reports quarterly results. Analysts weigh margin gains...
Boiling job growth can rattle markets, but a rapid rise in hiring doesn’t automatically trigger a crash. This guide b...
ServiceNow stock edged past the market as an analyst upgrade lifted sentiment. This article breaks down what moved NO...
Investors chase the next big energy winner as AI drives data centers demand. Oklo presents a high-risk, high-puture o...